In conclusion, with regard to the acute MI and post-MI protocols, it can be stated that, at the present time, only troponins, BNP, and NT-proBNP can be employed in clinical practice due to the established cut-offs, as well as optimal vitamin D values (30–60 ng/mL) [75]. This evidence concerns the gene NPPB and myocardial infarction.